Medical Malpractice in DMCC: Complete Guide

The DMCC licence is the commercial permission, not the clinical one

DMCC hosts a large number of health and wellness businesses: clinics, aesthetic and skin centres, physiotherapy and rehabilitation providers, telehealth platforms, nutrition and IV therapy services, and traders in medicines, devices and supplements. All of them hold a DMCC licence. Only some of them hold the health-sector licence they also need.

DMCC issues the commercial licence and requires third-party approval before a regulated activity can be added to it. The clinical regulator is the Dubai Health Authority, which licenses the facility, licenses each practitioner and sets the privileges attached to each licence. The free zone step and the health authority step are separate approvals with separate conditions, and the health authority is the body that receives a patient complaint.

Before opening, confirm in writing that the facility licence category covers every service on the price list, that each practitioner's licence lists the privileges the service actually requires, and that any medicines, injectables or devices held on site are permitted under the licence held. Medical liability insurance is a licensing condition — check that the policy names the procedures actually performed.

Aesthetics and wellness: the line that gets crossed

The most common enforcement problem in DMCC health businesses is not a bad clinical outcome. It is a treatment marketed as wellness that is legally a medical act. Injectables, threads, lasers, chemical peels at clinical strength, IV infusions and prescription-only products do not stop being medicine because the venue calls itself a studio or a lounge. The test is what is done to the patient and by whom, not how the service is described.

Three related traps recur. Non-medical staff performing acts reserved to licensed practitioners, often on the basis of a manufacturer's training certificate. A licensed practitioner supervising in name while absent in fact. And products sourced outside the regulated supply chain because a local distributor was slower or dearer. Any one of these converts a routine adverse event into an unlicensed-practice case, in which the clinical merits barely feature.

Advertising and patient acquisition

Health-related advertising in Dubai requires the health authority's prior approval, and this is where wellness businesses most often collide with the regulator. Before-and-after images, claims of guaranteed results, promotional discounting of medical procedures, campaigns run by influencers on the clinic's behalf and unapproved use of a practitioner's title are all treated as the clinic's own advertising, whoever posted them.

Keep a record of every approval obtained and match it to what is actually published, including social accounts and third-party posts you paid for. A patient who feels the outcome did not match the promise usually attaches the advertisement to the complaint, and the gap between the marketing claim and the consent form does more damage than the clinical event.

Consent, and the record behind it

A signed form proves a signature. What decides a case is whether the file shows that the patient was told, in a language they understood, what the procedure involved, what could go wrong, what alternatives existed and what the realistic outcome was. In elective aesthetic work the expectation-setting conversation is the case, so it belongs in the notes with the photographs, the product batch used, the dose and the practitioner's name.

The clinical record must show the presenting concern and examination findings, the reasoning behind the plan, the products and doses given with times, who performed what, and the follow-up. Three habits lose defensible cases: notes written after a complaint with nothing to mark them as late, templates copied forward so each visit reads identically, and results or follow-up calls that were never recorded.

How a complaint is decided

A patient complains to the health regulator. The regulator refers the matter to a medical liability committee, which reads the file and decides whether a medical error occurred and whether it was gross. That finding sets what follows: disciplinary measures against the practitioner or the facility, the evidential centre of any compensation claim, and — only for the narrow gross category — a criminal referral. A party who disagrees can escalate to the higher committee that reviews such findings, within the period the regulations specify.

Compensation claims are heard by the Dubai courts, in Arabic, with legal translations of the clinical file; DMCC is not a separate court system for a patient claim. Commercial contracts may route disputes to arbitration, and where they do the institution and the seat should be named rather than described. A patient's regulatory complaint cannot be excluded by contract.

Patient data

Clinical information about an identifiable person is among the most sensitive data the UAE regime protects, and a DMCC-licensed business handles it under the federal framework, Federal Decree-Law No. 45 of 2021, alongside the confidentiality duties that come with a medical licence.

The issues that arise in practice are specific to this sector. Clinical photographs used in marketing need consent for that use, given separately from consent to treatment, and a patient can withdraw it. Booking and CRM platforms hold treatment details and must be treated as clinical systems, not sales tools. Access should be restricted to treating staff. Retention periods should be set and applied. Where a platform or group system stores records outside the country, deal with the transfer properly before an incident forces the question.

Practitioners, contracts and premises

Engagement terms for practitioners should address clinical supervision, the privileges granted, incident reporting, cooperation with a regulator after the engagement ends, and insurance cover for past acts once a practitioner has left. Labelling a practitioner a contractor does not move regulatory responsibility away from the facility whose licence, premises and records are in use.

Premises matter too: the fit-out approved for the facility category, waste handling for clinical material, and storage conditions for medicines and injectables are inspected, and failures there are found quickly.

If a complaint arrives

• Secure the whole record immediately — notes, consent, photographs, product batch records, the electronic audit trail — and do not edit it.
• Take accounts from everyone involved while events are fresh.
• Answer the regulator within the period specified, addressing the clinical questions directly.
• Keep the clinician's explanation separate from the company's legal position and take advice before sending either.
• Speak to the patient early. An explanation is not an admission, and silence is what escalates complaints.

Because the committee's finding shapes everything after it, serious medical dispute resolution work belongs at the regulator stage rather than after the finding lands.

Conclusion

In DMCC the decisive questions are usually licensing and marketing rather than medicine: was the treatment a medical act performed under the right licence by a practitioner with the right privileges, was it advertised as approved, and was the patient told what could go wrong. Businesses that settle those three points before opening rarely face the cases that close their competitors.

For guidance on licensing a clinical or aesthetic service, an advertising approval or a complaint already with the regulator, contact the Nour Attorneys team.

Schedule Your Consultation

Disclaimer: The information provided in this article is for general informational purposes only and does not constitute legal advice. Readers should seek professional legal advice tailored to their specific circumstances before making any decisions or taking any action based on the content of this article.

Nour Attorneys Team

Related Resources

Explore more of our insights on related topics:

• Healthcare Facility Licensing Requirements in the UAE
• Medical Malpractice Defense Strategies for Dubai Clinics
• Pharmaceutical Compliance Guidelines for UAE Distributors
• Patient Privacy Regulations for Multinational Entities